₨ 1,888
Acuron 5ml Injection contains Atracurium Besylate, a neuromuscular blocking agent used in anesthesia to induce muscle relaxation during surgical procedures or mechanical ventilation. Atracurium Besylate works by competitively binding to nicotinic acetylcholine receptors at the neuromuscular junction, thereby blocking the action of acetylcholine and preventing muscle contraction.
Acuron 5ml Injection is primarily employed to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgeries. It is also utilized to maintain muscle relaxation during mechanical ventilation in critically ill patients in the intensive care unit.
Common side effects associated with Acuron 5ml Injection may include hypotension (low blood pressure), flushing, tachycardia (rapid heartbeat), bronchospasm, and allergic reactions such as rash or itching. Rare but severe side effects may involve prolonged paralysis, respiratory depression, and anaphylaxis. Vigilant monitoring of patients is essential to promptly address any adverse reactions during and after administration.
Before administering Acuron 5ml Injection, healthcare professionals should conduct a thorough assessment of the patient’s medical history, allergies, and current medications to ensure safe usage. Caution is advised in patients with underlying cardiovascular disease, neuromuscular disorders, or renal impairment. Adequate ventilation should be maintained, and airway management equipment should be readily available during administration to address any respiratory complications.
Acuron 5ml Injection is contraindicated in patients with a known hypersensitivity to Atracurium Besylate or any other components of the formulation. It should be avoided in patients with a history of malignant hyperthermia or severe electrolyte imbalances. Additionally, caution should be exercised when administering Acuron 5ml Injection to patients with myasthenia gravis or other neuromuscular diseases.
In summary, Acuron 5ml Injection is an essential medication in anesthesia practice, providing controlled muscle relaxation for surgical procedures and mechanical ventilation. While it offers significant clinical benefits, healthcare providers must remain vigilant for potential side effects and complications, taking appropriate precautions to ensure patient safety and optimal outcomes.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
These medicines also contain Atracurium Besylate, but in a different strength or pack. Do not switch to a different strength without asking your doctor.
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Atrelax 25mg injection | Abbott Laboratories | 25mg | Rs 285.31 |
| Tracrium 25mg injection | Glaxo Smithkline | 25mg | Rs 305.76 |
| Atrelax 50mg injection | Abbott Laboratories | 50mg | Rs 551.76 |
| Tracrium 50mg injection | Glaxo Smithkline | 50mg | Rs 588 |
| A Curium Injection | Aman Pharma | - | Rs 1,205 |
| Efacurim 50mg/5ml Injection | Surge Laboratories | 50mg/5ml | Rs 1,205.86 |
| Acuron Injection 3ml | Brookes Pharmaceutical Labs | 3ml | Rs 1,248 |
See all brands and prices on our Atracurium Besylate page.
You must be logged in to post a review.
No account yet?
Create an Account
Reviews
Clear filtersThere are no reviews yet.